Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rieske domain containing pseudogene 1 (UQCRFS1P1) is a human pseudogene predicted to resemble parts of the functional UQCRFS1 gene, which encodes the Rieske iron-sulfur subunit of mitochondrial complex III, but UQCRFS1P1 itself does not produce a functional protein[1][7]. The Rieske domain is associated with mitochondrial electron transport, specifically within the ubiquinol-cytochrome c reductase (cytochrome bc1) complex, but UQCRFS1P1 lacks evidence of biological activity. This locus is considered non-coding and is not considered a therapeutic target[1]. - *RFESDP1* is not the accepted or canonical abbreviation or name in recognized gene/protein nomenclature. - This pseudogene does not encode an active biological receptor, enzyme, or therapeutic target and is not implicated in drug interactions, human disease, or biomarker strategies[1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 pseudogene 1 (UQCRFS1P1).